Compare ALLO & PNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLO | PNRG |
|---|---|---|
| Founded | 2017 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 252.3M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | PNRG |
|---|---|---|
| Price | $1.38 | $175.64 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 50.3K |
| Earning Date | 11-06-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 10.31 |
| Revenue | N/A | ★ $196,237,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | ★ N/A | $17.04 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.86 | $126.40 |
| 52 Week High | $3.78 | $243.49 |
| Indicator | ALLO | PNRG |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 53.06 |
| Support Level | $1.32 | $162.83 |
| Resistance Level | $1.52 | $170.17 |
| Average True Range (ATR) | 0.10 | 7.81 |
| MACD | -0.02 | -1.25 |
| Stochastic Oscillator | 28.57 | 38.32 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and providing well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.